This preparative liquid chromatography system is intended for purification of highly potent pharmaceutical compounds. It is suitable for selected anticancer agents, hormones, cytotoxic substances, immunosuppressants, and genotoxic materials. These products may have therapeutic doses at the microgram level and present carcinogenic, teratogenic, reproductive, or other toxicological risks. The system is designed around OEB5 containment requirements. The stated occupational exposure limit is typically no more than 0.1 µg/m³ as an eight-hour time-weighted average. Engineering controls are used to limit operator and environmental exposure during chromatographic processing. The contained design can cover material charging, separation, fraction collection, sampling, and discharge according to the selected configuration. Personal protective measures can supplement the equipment-level containment strategy. Process modules and containment interfaces can be customized for the compound, solvent system, batch scale, and production workflow.
Specification
Model: OEB5 Preparative Liquid Chromatography System Containment classification: OEB5 Stated occupational exposure limit: ≤0.1 µg/m³ Exposure basis: 8-hour time-weighted average Target compounds: Anticancer drugs, hormones, cytotoxic compounds, immunosuppressants, and genotoxic substances Process type: Preparative liquid chromatography Control approach: Engineering containment combined with personal protection Configuration: Customizable according to compound, solvent, scale, and workflow
Features
OEB5 high-containment design Suitable for highly potent compounds Exposure target ≤0.1 µg/m³ Supports toxic and genotoxic materials Engineering-controlled processing Configurable contained workflow Preparative purification capability Customizable process interfaces